SynthesisDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2026
The Impact of Artificial Intelligence-Assisted Endoscopy on the Detection of Upper Gastrointestinal Neoplasms: A Systematic Review and Meta-Analyses.
Synthesis in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesEarly detection of upper gastrointestinal (UGI) neoplasms is challenging because of their subtle endoscopic features. Artificial intelligence (AI) has improved endoscopic imaging and lesion recognition. This meta-analysis aimed to assess the effectiveness of AI-assisted real-time esophagogastroduodenoscopy (EGD) for detecting UGI neoplasms based on evidence from randomized controlled trials (RCTs).
methodsPubMed, EMBASE, and Cochrane Library were searched for RCTs comparing AI-assisted EGD with conventional EGD up to April 11, 2026. Risk ratios (RRs) were calculated for the neoplasm detection rate (DR), and incidence rate ratios (IRRs) were pooled for lesions per endoscopy (LPE). Subgroup analyses were conducted according to AI system and pathological types. Random-effects models with Hartung-Knapp adjustment were applied.
resultsTen RCTs involving 87,721 participants were included. Compared with conventional EGD, AI-assisted EGD significantly improved neoplasm DRs in the esophagus (RR = 1.47, 95% confidence interval [CI] 1.13-1.90, p = 0.012) and stomach (RR = 1.47, 95% CI 1.02-2.13, p = 0.043). In subgroup analyses, computer-assisted detection (CADe) was associated with increased LPE of esophageal neoplasms (IRR = 1.62, 95% CI 1.08-2.45, p = 0.033). AI-assisted EGD also increased the LPEs of gastric cancer (IRR = 1.45, 95% CI 1.09-1.92, p = 0.022) and low-grade intraepithelial neoplasia (IRR = 1.39, 95% CI 1.13-1.70, p = 0.012).
conclusionsAI-assisted real-time EGD was associated with improved detection of UGI neoplasms and may support endoscopists in routine clinical practice. Further studies are required to evaluate the effectiveness of different AI systems across pathological subtypes.
trial registrationPROSPERO; CRD420251158943.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.